InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Biodexa Pharmaceuticals Plc

BDRX Clue Score36
United Kingdom Fiscal year ends December CIK 0001643918
$0.38 -16.73% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.38 −77.59% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1.3Operating income−9.7Net income−20.2Fiscal year 2017Revenue1.0 −25.2%Operating income−13.3Net income−16.1Fiscal year 2018Revenue1.9 +96.0%Operating income−11.8Net income−15.0Fiscal year 2019Revenue0.7 −65.2%Operating income−11.3Net income−10.1Fiscal year 2020Revenue0.3 −49.1%Operating income−23.0Net income−22.2Fiscal year 2021Revenue0.6 +68.5%Operating income−7.0Net income−5.5Fiscal year 2022Revenue0.7 +20.9%Operating income−8.9Net income−7.7EPS, diluted−1.55Fiscal year 2023Revenue0.4 −45.5%Operating income−8.0Net income−7.1EPS, diluted−0.02Fiscal year 2024Operating income−9.2Net income−5.7EPS, diluted−0.00Fiscal year 2025Operating income−8.6Net income−6.4EPS, diluted−0.00
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.3 1.0 1.9 0.7 0.3 0.6 0.7 0.4 n/a n/a
Growth −25.2% +96.0% −65.2% −49.1% +68.5% +20.9% −45.5%
Operating income −9.7 −13.3 −11.8 −11.3 −23.0 −7.0 −8.9 −8.0 −9.2 −8.6
Net income −20.2 −16.1 −15.0 −10.1 −22.2 −5.5 −7.7 −7.1 −5.7 −6.4
Growth
EPS, diluted n/a n/a n/a n/a n/a n/a −1.55 −0.02 −0.00 −0.00
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin472.9%Operating margin−729.6%Net margin−1,524.0%Free cash flow margin−1,090.9%Fiscal year 2017Gross margin674.6%Operating margin−1,342.4%Net margin−1,624.3%Free cash flow margin−1,381.2%Fiscal year 2018Operating margin−609.6%Net margin−775.5%Free cash flow margin−706.6%Fiscal year 2019Operating margin−1,679.2%Net margin−1,496.3%Free cash flow margin−1,008.8%Fiscal year 2020Operating margin−6,717.2%Net margin−6,469.1%Free cash flow margin−2,772.6%Fiscal year 2021Operating margin−1,210.7%Net margin−944.6%Free cash flow margin−1,094.8%Fiscal year 2022Operating margin−1,277.8%Net margin−1,095.3%Free cash flow margin−1,017.2%Fiscal year 2023Operating margin−2,103.4%Net margin−1,858.0%Free cash flow margin−1,798.4%Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 472.9% 674.6% n/a n/a n/a n/a n/a n/a n/a n/a
Operating margin −729.6% −1,342.4% −609.6% −1,679.2% −6,717.2% −1,210.7% −1,277.8% −2,103.4% n/a n/a
Net margin −1,524.0% −1,624.3% −775.5% −1,496.3% −6,469.1% −944.6% −1,095.3% −1,858.0% n/a n/a
Free cash flow margin −1,090.9% −1,381.2% −706.6% −1,008.8% −2,772.6% −1,094.8% −1,017.2% −1,798.4% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−13.1Capital expenditure−1.3Free cash flow−14.4Fiscal year 2017Operating cash flow−13.0Capital expenditure−0.7Free cash flow−13.7Fiscal year 2018Operating cash flow−13.5Capital expenditure−0.2Free cash flow−13.7Fiscal year 2019Operating cash flow−6.5Capital expenditure−0.3Free cash flow−6.8Fiscal year 2020Operating cash flow−9.3Capital expenditure−0.2Free cash flow−9.5Fiscal year 2021Operating cash flow−6.0Capital expenditure−0.3Free cash flow−6.3Fiscal year 2022Operating cash flow−7.0Capital expenditure−0.1Free cash flow−7.1Fiscal year 2023Operating cash flow−6.8Capital expenditure−0.0Free cash flow−6.9Fiscal year 2024Operating cash flow−12.3Capital expenditure−0.0Free cash flow−12.3Fiscal year 2025Operating cash flow−5.6Capital expenditure−0.0Free cash flow−5.6
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −13.1 −13.0 −13.5 −6.5 −9.3 −6.0 −7.0 −6.8 −12.3 −5.6
Capital expenditure −1.3 −0.7 −0.2 −0.3 −0.2 −0.3 −0.1 −0.0 −0.0 −0.0
Free cash flow −14.4 −13.7 −13.7 −6.8 −9.5 −6.3 −7.1 −6.9 −12.3 −5.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash17.6Total debt1.6Net cash (debt)16.0Shareholders’ equity45.7Debt to equity0.04Fiscal year 2017Cash13.2Total debt6.2Net cash (debt)7.0Shareholders’ equity34.7Debt to equity0.18Fiscal year 2018Cash2.3Total debt0.9Net cash (debt)1.5Shareholders’ equity16.9Debt to equity0.05Fiscal year 2019Cash10.9Total debt5.7Net cash (debt)5.3Shareholders’ equity19.6Debt to equity0.29Fiscal year 2020Cash7.5Total debt0.1Net cash (debt)7.5Shareholders’ equity6.7Debt to equity0.01Fiscal year 2021Cash10.1Total debt0.6Net cash (debt)9.4Shareholders’ equity10.5Debt to equity0.06Fiscal year 2022Cash2.8Total debt0.5Net cash (debt)2.4Shareholders’ equity3.2Debt to equity0.15Fiscal year 2023Cash6.0Total debt0.3Net cash (debt)5.7Shareholders’ equity4.7Debt to equity0.06Fiscal year 2024Cash1.7Total debt0.1Net cash (debt)1.6Shareholders’ equity8.3Debt to equity0.01Fiscal year 2025Cash8.5Shareholders’ equity11.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 17.6 13.2 2.3 10.9 7.5 10.1 2.8 6.0 1.7 8.5
Total debt 1.6 6.2 0.9 5.7 0.1 0.6 0.5 0.3 0.1 n/a
Net cash (debt) 16.0 7.0 1.5 5.3 7.5 9.4 2.4 5.7 1.6 n/a
Shareholders’ equity 45.7 34.7 16.9 19.6 6.7 10.5 3.2 4.7 8.3 11.4
Debt to equity 0.04 0.18 0.05 0.29 0.01 0.06 0.15 0.06 0.01 n/a

In millions of GBP, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of GBP, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
1.3 1.0 1.9 0.7 0.3 0.6 0.7 0.4 n/a n/a
Growth −25.2% +96.0% −65.2% −49.1% +68.5% +20.9% −45.5%
0.7 0.9 n/a n/a n/a n/a n/a n/a n/a n/a
6.3 6.7 n/a n/a n/a n/a n/a n/a n/a n/a
Growth +6.6%
7.7 8.3 9.4 7.8 6.1 4.7 5.1 4.1 5.4 4.0
−9.7 −13.3 −11.8 −11.3 −23.0 −7.0 −8.9 −8.0 −9.2 −8.6
Growth
−8.4 −13.0 −12.4 −10.9 −23.5 −6.1 −8.5 −7.5 −6.0 −6.5
−2.2 −1.3 −2.0 1.8 −1.3 −0.6 −0.8 −0.4 −0.3 −0.1
−20.2 −16.1 −15.0 −10.1 −22.2 −5.5 −7.7 −7.1 −5.7 −6.4
Growth
Per share
n/a n/a n/a n/a n/a n/a −1.55 −0.02 −0.00 −0.00
n/a n/a n/a n/a n/a n/a −1.55 −0.02 −0.00 −0.00
Growth
36.1 2.6 3.1 18.3 2.1 4.0 4.9 315.8 4,953 54,861

Shown in GBP as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 27.8% a year over five years.
  • Operating margin is down 1,493.8 points on five years ago, at -2,103.4%.
  • A net loss in 10 of 10 years on file.